MedPath

Cognitive Complaints in Obstructive Sleep Apnea

Completed
Conditions
Cognition Disorders
Sleep Apnea Syndromes, Obstructive
Interventions
Behavioral: questionnaires and neuropsychological assessments
Registration Number
NCT02769663
Lead Sponsor
VieCuri Medical Centre
Brief Summary

The study assesses cognitive complaints in newly diagnosed patients with obstructive sleep apnea with no medical-comorbity affecting cognition. Cognitive complaints will be compared to healthy controls matched on age, sex and educational level. Factors related to cognitive complaints will also be assessed, including anxiety and depressive symptoms, complaints of fatigue and sleepiness, quality of life, psychological coping strategies and objective measures of cognition. Patients starting treatment for sleep apnea (continuous positive airway pressure or mandibular repositioning device) will be reassessed on all measures after 6 months of treatment to study the impact of treatment as usual on cognitive complaints and its related factors.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • native Dutch speaker
  • estimated verbal-IQ of ≥80
Exclusion Criteria
  • other sleep disorder than obstructive sleep apnea
  • substance or alcohol abuse (e.g. no more than three units of alcohol per day for males and no more than two units of alcohol per day for females
  • diagnosis of a psychiatric disorder
  • use of medication effecting cognition
  • neurological disease, diabetes mellitus, hypo- or hyperthyroidism or lung disease (as checked by verbal report and medical records)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
OSAquestionnaires and neuropsychological assessmentsPatients with newly diagnosed obstructive sleep apnea and no medical comorbidity affecting cognition.
healthy controlsquestionnaires and neuropsychological assessmentsParticipants with no sleep disorder or other medical comorbidity affecting cognition.
Primary Outcome Measures
NameTimeMethod
Cognitive Failure Questionnaire (CFQ)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

Questionnaire assessing cognitive complaints

Behavior Rating Inventory of Executive Function Adult version (BRIEF-A)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

Questionnaire assessing cognitive complaints

Secondary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scale (HADS)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire assessing anxiety and depressive symptoms

Fatigue Assessment Scale (FAS)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire assessing fatigue

Epworth Sleepiness Scale (ESS)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire assessing sleepiness

Pittsburgh Sleep Quality Index (PSQI)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire screening for sleep disorders and assessing sleep quality

Sleep diaryAssessed at inclusion of study and, if treatment is started, after 6 months of treatment.

subjective measure for sleep quality

World Health Organisation Quality of Life Questionnaire BREF (WHOQOL-bref)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire measuring quality of life

Utrechtse Coping Lijst (UCL)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

questionnaire measuring psychological coping strategies

Dutch reading tests for adults (NLV)Assessed at inclusion of study.

cognitive test for verbal intelligence

Central Nervous System Vital Signs Symbol Digit Coding (CNS-VS-SDC)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention

Central Nervous System Vital Signs Continuous Performance Test (CNS-VS-CPT)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention

Central Nervous System Vital Signs Stroop Test (CNS-VS-ST)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention/executive function

Central Nervous System Vital Signs Shifting Attention Test (CNS-VS-SAT)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention/executive function

Rey Auditory Verbal Learning Test (RAVLT)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for memory

Wechsler Adult Intelligence Scale III - Digit Span (WAIS-III-DS)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention/executive function

Trail Making Test (TMT)Assessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for attention/executive function

Semantic FluencyAssessed at inclusion of study and, if treatment is started, after 6 months of treatment.

cognitive test for executive function

Trial Locations

Locations (2)

VieCuri Medisch Centrum

🇳🇱

Venlo, Limburg, Netherlands

Reinier de Graaf Gasthuis

🇳🇱

Delft, Zuid-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath